<ul><li>Pfizer's hotly tipped breast cancer prospect delivers phase 2 win</li><li>Aspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trial</li><li>Crossbow hits $77M series B round to bankroll quiver of T-Bolts</li></ul>

Pfizer's hotly tipped breast cancer prospect delivers phase 2 winAspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trialCrossbow hits $77M series B round to bankroll quiver of T-Bolts

Episode#31 Mar 18th 2026: Pfizer’s atirmociclib phase 2 win

A fast paced, AI-generated podcast on pharma and biotech news.

Share Episode#31 Mar 18th 2026: Pfizer’s atirmociclib phase 2 win

Sign up to save your podcasts

Episode#31 Mar 18th 2026: Pfizer’s atirmociclib phase 2 win

Episode#31 Mar 18th 2026: Pfizer’s atirmociclib phase 2 win